2003
DOI: 10.1291/hypres.26.141
|View full text |Cite
|
Sign up to set email alerts
|

A/C1166 Gene Polymorphism of the Angiotensin II Type 1 Receptor (AT1) and Ambulatory Blood Pressure: The Ohasama Study.

Abstract: We previously investigated the relation between hypertension and each of three major genetic polymorphisms in the renin-angiotensin (AGT)-aldosterone system (R-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0
3

Year Published

2003
2003
2017
2017

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 21 publications
1
28
0
3
Order By: Relevance
“…The interplay between environmental and genetic factors is a major determinant of the final phenotype in hypertension [2]. Several genes: angiotensinogen gene (AGT), angiotensin I-converting enzyme (ACE), angiotensin II type 1-receptor (AT1-R) and angiotensin II type 2-receptor (AT2-R) have been reported an association with hypertension [7][8][9][10][11]. ACE is the major enzyme of the reninangiotensin-aldosterone system (RAAS), functions conversion of angiotensin I to angiotensin II which binds to plasma membrane receptors, producing arteriolar constriction and a rise in systolic and diastolic blood pressure.…”
Section: Introductionmentioning
confidence: 99%
“…The interplay between environmental and genetic factors is a major determinant of the final phenotype in hypertension [2]. Several genes: angiotensinogen gene (AGT), angiotensin I-converting enzyme (ACE), angiotensin II type 1-receptor (AT1-R) and angiotensin II type 2-receptor (AT2-R) have been reported an association with hypertension [7][8][9][10][11]. ACE is the major enzyme of the reninangiotensin-aldosterone system (RAAS), functions conversion of angiotensin I to angiotensin II which binds to plasma membrane receptors, producing arteriolar constriction and a rise in systolic and diastolic blood pressure.…”
Section: Introductionmentioning
confidence: 99%
“…Genetic factors are likely to be involved in this difference in response (6,7). The renin-angiotensin-aldosterone system (RAAS), which has a central role in the maintenance of body fluid and blood pressure, is involved in the development of hypertension, and several genes in this system, such as the angiotensinogen (AGT), angiotensin I-converting enzyme (ACE), angiotensin II type 1 receptor (AT1-R) and angiotensin II type 2 receptor (AT2-R) genes, have been reported to have an association with hypertension (8)(9)(10)(11)(12). ACE is the key enzyme of the RAAS, and its insertion-deletion polymorphism (ACE I/D) in intron 16 is the most studied polymorphism in the RAAS.…”
Section: Introductionmentioning
confidence: 99%
“…27 Genetic polymorphisms and diurnal BP variation Daytime SBP and diastolic blood pressure (DBP) values were higher in individuals with the C allele in the angiotensin II type 1 receptor gene A/C 1166 polymorphism (130.5 ± 14.0/77.4 ± 8.3 mm Hg) than in those with the AA genotype (127.7 ± 13.6/75.8 ± 8.3 mm Hg, P¼0.03/0.04), although the difference was not statistically significant after adjusting for age, gender, body mass index and smoking status. 28 Nighttime BP values were significantly lower among individuals with the MM genotype in the angiotensinogen M235T polymorphism than in those with the T allele (105.2±13.0/60.1±6.9 vs. 110.6±13.3/ 63.6 ± 7.8 mm Hg, P¼0.04/0.02). The nocturnal decline in BP was significantly larger among those with the MM genotype than with the T allele (17.4/19.8 vs. 13.5/16.2 mm Hg, P¼0.004/0.01).…”
Section: Diurnal Bp Variation and Target-organ Damagementioning
confidence: 84%